The Chairman of the organizing committee, Per, is managing manager for DISA Global Solution AB in Stockholm and president of the European Workplace Drug Testing Society (EWDTS). Per wrote the first European collection guidelines for EWDTS. His vision for a better global drug testing industry and society led to his creation of the International Forum for Drug and Alcohol Testing.
Born in Uppsala, Sweden, Mr. Bjorklov studied teaching, information and marketing at the University of Stockholm and biology and geography at the University of Uppsala. In 1991 he began his work at the Department of Pharmacology at Karolinska University Hospital in Huddinge (Stockholm) on the "workplace drug testing" project. Mr. Bjorklov was the initiator of the first European Symposium on Drug testing and the European Workplace Drug Testing Society.
Per took the initiative to start the IFDAT conferences back in 2005 together with Dr Anthony Wong from Brazil, Sue Nolan from New Zealand and Kurt Bothner from USA.
Anthony Wong organized the first IFDAT meeting in Sao Paulo, Brazil in 2008, with the help of Per Bjoklov and Sue Nolan. He was appointed Vice President of IFDAT since 2010. Anthony Wong is a physician, with a MD degree from the School of Medicine of the University of Sao Paulo and holds a PhD degree in Clinical Toxicology rom the same University.
He is Medical and Scientific Director of MAXILABOR Diagnósticos, a company for drug and alcohol testing, since 1999. MAXILABOR holds the ISO 17025 accreditation for drug testing since 2006, the first and only laboratory based in Latin America thus accredited. Since the foundation of the company, it has been the vision and policy that drug use and abuse is a treatable condition, MAXILABOR has established the guidelines and norms for drug testing and policies in Brazil. The CUIDE Programme is a 5-step protocol that guides through company policy to treatment and rehab process. Government and medical societies in Latin America, particularly in Brazil, are very strict of privacy issues and personal information. The guidelines set forth by MAXILABOR have been adopted by most large corporations and even by federal agencies in Brazil.
He is Professor of Clinical Toxicology at the School of Medicine of the University of Sao Paulo, where he also is Chief of the CEATOX (Poison Response Centre). CEATOX is reputed to be the most prestigious centre for poison information and pharmacovigilance in Brazil. It is the only non-governmental organisation to be part of the Uppsala Monitoring Centre for the Drug Safety Programme of the World Health Organisation.
In 2010, he was elected to serve on the Nomenclature, Safety and Labeling Committee Council of Experts of the United States Pharmacopeial Convention (USP) for a five-year term. In 2014, he was nominated and elected to the Brazilian Academy of Pharmacy and Pharmaceutical Sciences. He was Past-President of the Brazilian Society of Toxiclogy.
He is an active member of the American Academy of Clinical Toxicology, the Brazilian Society of Paediatrics and the Brazilian Society of Intensive Medicine.